26Aug
Financial Daily Dose 8.26.2019 | Top Story: Amgen to Pay More Than $13 Billion for Otezla
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....
By:
Robins Kaplan LLP
Related
"It could have been worse" edition. This year was kind of meh from an employment law standpoint. Bu...
Read More >
Consumer Protection- When “Free” Trials Come With Strings Attached: Attorneys General Ask FTC to ...
Read More >
Employers found to have misclassified employees as independent contractors will no longer face the p...
Read More >
Wage and Hour - 80/20 Rule Still Followed in Some Parts - The U.S. Department of Labor (DOL) iss...
Read More >
The Situation:The U.S. Department of Justice ("DOJ") has sued to block a proposed acquisition of Ale...
Read More >
The Situation: The U.S. Supreme Court unanimously held that filing a charge of discrimination with t...
Read More >